Archives
-
AM 281 and the CB1-CREB-GLT-1 Axis
2026-09-09
AM 281 offers a selective pharmacological entry point for testing how CB1 signaling regulates astrocytic GLT-1, glutamate excitotoxicity, and cognitive dysfunction after traumatic brain injury. This article translates recent CB1-CREB-GLT-1 findings into practical experimental and translational guidance.
-
Cy7 NHS Ester (A8109): Practical Labeling Guide
2026-09-09
Cy7 NHS ester (SKU A8109) is a water-soluble near-infrared dye for bioimaging that supports aqueous labeling of proteins, peptides, and other amino-containing biomolecules. It is useful for near-infrared fluorescent imaging and biomolecule conjugation, but it is not intended for non-amine labeling or long-term storage of prepared dye solutions.
-
Mouse Neutrophil Cell Isolation Kit Workflow
2026-09-08
Build a rapid, column-free workflow for high-purity mouse neutrophils from bone marrow, blood, or spleen while minimizing target-cell activation. The negative-selection format is especially useful for functional assays supporting neutrophil-targeted nanomedicine and tumor-immunology research.
-
In Vitro Drug Response: Viability Versus Cell Death
2026-09-08
Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. By separating growth inhibition from actual cell killing and considering their timing, the study provides a more interpretable framework for drug-response experiments and apoptosis-focused cancer research.
-
Ceramides Drive RGNNV Replication via Autophagy
2026-09-07
The reference study uses global lipidomics and targeted pathway perturbation to show that red-spotted grouper nervous necrosis virus (RGNNV) increases ceramide production and exploits ceramide-dependent autophagy for replication. Its rescue experiments with C16-ceramide identify sphingolipid metabolism as a mechanistically actionable host factor, while also defining important limits for transfer to other cell and disease models.
-
Firefly Luciferase mRNA Workflow Guide
2026-09-07
Build sensitive reporter assays with Cap1-capped, 5-moUTP modified mRNA designed for durable translation and reduced innate immune recognition. This guide connects practical transfection optimization with sex-aware interpretation of preclinical mRNA-LNP studies.
-
Hoechst 33342 for Live-Cell Nuclear Assays
2026-09-05
Hoechst 33342 combines rapid live-cell nuclear labeling with a compact blue-fluorescence workflow for chromatin visualization, cell cycle analysis, and apoptosis-oriented imaging. Its greatest practical value in transport studies is as a nuclear landmark that complements, rather than replaces, cargo labeling and force measurements.
-
Fluorouracil in Cancer Research: Practical Workflows
2026-09-04
Build reproducible 5-Fluorouracil assays around thymidylate synthase inhibition, DNA-replication stress, and orthogonal phenotypic readouts. This workflow also shows how the SMC2/SMC4 breast cancer findings can guide biomarker-stratified sensitivity experiments without overstating translational evidence.
-
RSL3 Workflow for Ferroptosis Research
2026-09-04
Build more decisive ferroptosis assays with RSL3, a direct GPX4 perturbation tool for redox-sensitive cancer models and mechanistic validation. This workflow also shows how RSL3 can complement nerve-injury studies by separating lipid-peroxidation causality from antioxidant rescue.
-
MVC, RhoA/ROCK1 Signaling, and Tight Junction Entry
2026-09-03
Ren et al. show that Minute Virus of Canines (MVC) VP2 interacts with ROCK1 and activates the RhoA/ROCK1/MLC2 axis, remodeling tight junctions and exposing Occludin during infection. The study provides a mechanistic framework for understanding MVC entry and for testing pathway-directed interventions, while its conclusions remain primarily grounded in a canine cell-culture model.
-
Sabutoclax Workflows for Apoptosis Assays
2026-09-03
Sabutoclax supports mechanism-aware cancer assays that separate growth inhibition from true cell killing. This workflow combines pan-Bcl-2 pathway coverage, orthogonal apoptosis readouts, and genotype-aware controls to improve interpretation in cell and xenograft studies.
-
Amorolfine Hydrochloride and Fungal Cell Limits
2026-09-02
A translational perspective on how Amorolfine Hydrochloride can help researchers connect fungal membrane biosynthesis, ploidy-associated stress, assay design, and antifungal resistance studies.
-
Rotigotine: From Receptor Signal to PD Assay
2026-09-02
Rotigotine is more than a dopamine D2/D3 receptor agonist: it is a versatile probe for connecting receptor pharmacology, exposure design, and neuroprotective phenotypes. This guide translates continuous dopaminergic delivery concepts into rigorous Parkinson’s disease research assays.
-
From Reporter Signal to Smarter mRNA Delivery
2026-09-01
Firefly Luciferase mRNA can function as more than a bright endpoint: it can help translational teams resolve how capping, nucleoside modification, poly(A) architecture, and delivery vehicles shape expression, persistence, and immune context.
-
MVC Entry via RhoA/ROCK1/MLC2 Signaling
2026-09-01
The reference study identifies a previously unreported interaction between MVC VP2 and the kinase domain of ROCK1 and links this interaction to RhoA/ROCK1/MLC2-driven tight-junction disruption. Its experiments support Occludin as a potential co-receptor and show that pathway inhibition can reduce MVC-associated barrier permeability, viral protein expression, and genomic copy number in canine cells.